Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1982 Apr;48(1):43–51.

Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis.

R M Bernstein, J C Steigerwald, E M Tan
PMCID: PMC1536562  PMID: 7044633

Abstract

Antinuclear and/or antinucleolar antibodies were demonstrated in the sera of 74 of 76 patients (97%) with progressive systemic sclerosis, using tissue culture cells (HEp-2) as substrate in the indirect immunofluorescent method. Six patterns of nuclear staining and three nucleolar patterns were recognized. The nuclear patterns were centromere, fine speckles, coarse speckles, diffusely grainy, homogeneous and nuclear dots. The nucleolar patterns were speckled, homogeneous and clumpy. The results of digestion studies with ribonuclease, deoxyribonuclease and trypsin suggested that the nuclear antigens are proteins, some of which may be associated with chromatin. The nucleolar antigens appeared to be nucleic acid in nature. Certain characteristic serologic and clinical features associated with staining patterns were observed. The diffusely grainy pattern was seen only in sera containing antibody to Scl-70 antigen. Centromere staining was confirmed to be highly selective for the CREST (Calcinosis, Raynaud's phenomenon, esophageal involvement, sclerodactyly and telangiectasis) variant of progressive systemic sclerosis with rheumatoid factor titres higher in these patients with anti-centromere antibodies.

Full text

PDF
43

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alspaugh M., Maddison P. Resolution of the identity of certain antigen-antibody systems in systemic lupus erythematosus and Sjögren's syndrome: an interlaboratory collaboration. Arthritis Rheum. 1979 Jul;22(7):796–798. doi: 10.1002/art.1780220719. [DOI] [PubMed] [Google Scholar]
  2. Aslpaugh M. A., Tan E. M. Serum antibody in rheumatoid arthritis reactive with a cell-associated antigen. Demonstration by precipitation and immunofluorescence. Arthritis Rheum. 1976 Jul-Aug;19(4):711–719. doi: 10.1002/1529-0131(197607/08)19:4<711::aid-art1780190409>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  3. BECK J. S. AUTO-ANTIBODIES TO CELL NUCLEI. Scott Med J. 1963 Oct;8:373–388. doi: 10.1177/003693306300801001. [DOI] [PubMed] [Google Scholar]
  4. BECK J. S. Variations in the morphological patterns of "autoimmune" nuclear fluorescence. Lancet. 1961 Jun 3;1(7188):1203–1205. doi: 10.1016/s0140-6736(61)91944-4. [DOI] [PubMed] [Google Scholar]
  5. Burnham T. K., Bank P. W. Antinuclear antibodies. I. Patterns of nuclear immunofluorescence. J Invest Dermatol. 1974 May;62(5):526–534. doi: 10.1111/1523-1747.ep12681110. [DOI] [PubMed] [Google Scholar]
  6. Burnham T. K., Fine G., Neblett T. R. The immunofluorescent tumor imprint technique. II. The frequency of antinuclear factors in connective tissue diseases and dermatoses. Ann Intern Med. 1966 Jul;65(1):9–19. doi: 10.7326/0003-4819-65-1-9. [DOI] [PubMed] [Google Scholar]
  7. Douvas A. S., Achten M., Tan E. M. Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma. J Biol Chem. 1979 Oct 25;254(20):10514–10522. [PubMed] [Google Scholar]
  8. FENNELL R. H., Jr, RODNAN G. P., VAZQUEZ J. J. Variability of tissue-localizing properties of serum from patients with different disease states. Lab Invest. 1962 Jan;2:24–31. [PubMed] [Google Scholar]
  9. Fritzler M. J., Kinsella T. D. The CREST syndrome: a distinct serologic entity with anticentromere antibodies. Am J Med. 1980 Oct;69(4):520–526. doi: 10.1016/0002-9343(80)90462-3. [DOI] [PubMed] [Google Scholar]
  10. Miyawaki S., Ritchie R. F. Nucleolar antigen specific for antinucleolar antibody in the sera of patients with systemic rheumatic disease. Arthritis Rheum. 1973 Nov-Dec;16(6):726–736. doi: 10.1002/art.1780160605. [DOI] [PubMed] [Google Scholar]
  11. Moroi Y., Peebles C., Fritzler M. J., Steigerwald J., Tan E. M. Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1627–1631. doi: 10.1073/pnas.77.3.1627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Notman D. D., Kurata N., Tan E. M. Profiles of antinuclear antibodies in systemic rheumatic diseases. Ann Intern Med. 1975 Oct;83(4):464–469. doi: 10.7326/0003-4819-83-4-464. [DOI] [PubMed] [Google Scholar]
  13. Pinnas J. L., Northway J. D., Tan E. M. Antinucleolar antibodies in human sera. J Immunol. 1973 Oct;111(4):996–1004. [PubMed] [Google Scholar]
  14. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Bull Rheum Dis. 1981;31(1):1–6. [PubMed] [Google Scholar]
  15. Ritchie R. F. Antinucleolar antibodies. Their frequency and diagnostic association. N Engl J Med. 1970 May 21;282(21):1174–1178. doi: 10.1056/NEJM197005212822104. [DOI] [PubMed] [Google Scholar]
  16. Ritchie R. F. Nucleolar structure by immunologic technics. Cancer Res. 1969 Jan;29(1):267–269. [PubMed] [Google Scholar]
  17. Rothfield N. F., Rodnan G. P. Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma). Arthritis Rheum. 1968 Oct;11(5):607–617. doi: 10.1002/art.1780110502. [DOI] [PubMed] [Google Scholar]
  18. Tan E. M. Relationship of nuclear staining patterns with precipitating antibodies in systemic lupus erythematosus. J Lab Clin Med. 1967 Nov;70(5):800–812. [PubMed] [Google Scholar]
  19. Tan E. M., Rodnan G. P., Garcia I., Moroi Y., Fritzler M. J., Peebles C. Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome. Arthritis Rheum. 1980 Jun;23(6):617–625. doi: 10.1002/art.1780230602. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES